References
- Bramerson A, Johansson L, Ek L, Nordin S, Bende M. Prevalence of olfactory dysfunction: the skövde population-based study. Laryngoscope 2004;114:733–7.
- Damm M, Temmel A, Welge-Lussen A, Eckel HE, Kreft MP, Klussmann JP, et al. [Olfactory dysfunctions. Epidemiology and therapy in Germany, Austria and Switzerland]. HNO 2004;52:112–20.
- Wolfensberger M, Hummel T. Anti-inflammatory and surgical therapy of olfactory disorders related to sino-nasal disease. Chem Senses 2002;27:617–22.
- Stevens MH. Steroid-dependent anosmia. Laryngoscope 2001;111:200–3.
- Blomqvist EH, Lundblad L, Bergstedt H, Stjärne P. Placebo-controlled, randomized, double-blind study evaluating the efficacy of fluticasone propionate nasal spray for the treatment of patients with hyposmia/anosmia. Acta Otolaryngol 2003;123:862–8.
- Stenner M, Vent J, Huttenbrink KB, Hummel T, Damm M. Topical therapy in anosmia: relevance of steroid-responsiveness. Laryngoscope 2008;118:1681–6.
- Scheibe M, Bethge C, Witt M, Hummel T. Intranasal administration of drugs. Arch Otolaryngol Head Neck Surg 2008;134:643–6.
- Shu CH, Lee PL, Shiao AS, Chen KT, Lan MY. Topical corticosteroids applied with a squirt system are more effective than a nasal spray for steroid-dependent olfactory impairment. Laryngoscope 2012;122:747–50.
- Stjarne P, Mosges R, Jorissen M, Passali D, Bellussi L, Staudinger H, et al. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg 2006;132:179–85.
- Shu CH, Yuan BC. Assessment of odor identification function in Asia using a modified “Sniffin’ Stick odor identification test”. Eur Arch Otorhinolaryngol 2008;265:787–90.
- Gudziol V, Lotsch J, Hahner A, Zahnert T, Hummel T. Clinical significance of results from olfactory testing. Laryngoscope 2006;116:1858–63.
- Seiden AM, Duncan HJ. The diagnosis of a conductive olfactory loss. Laryngoscope 2001;111:9–14.
- Fong KJ, Kern RC, Foster JD, Zhao JC, Pitovski DZ. Olfactory secretion and sodium, potassium-adenosine triphosphatase: regulation by corticosteroids. Laryngoscope 1999;109:383–8.
- Mueller C, Temmel AF, Toth J, Quint C, Herneth A, Hummel T. Computed tomography scans in the evaluation of patients with olfactory dysfunction. Am J Rhinol 2006;20:109–12.
- Rudman KL, O'Brien EK, Leopold DA. Radiographic distribution of drops and sprays within the sinonasal cavities. Am J Rhinol Allergy 2011;25:94–7.
- Mott AE, Leopold DA. Disorders in taste and smell. Med Clin North Am 1991;75:1321–53.
- Mori E, Merkonidis C, Cuevas M, Gudziol V, Matsuwaki Y, Hummel T. The administration of nasal drops in the “Kaiteki” position allows for delivery of the drug to the olfactory cleft: a pilot study in healthy subjects. Eur Arch Otorhinolaryngol 2016;273:939–43.
- Reychler G, Colbrant C, Huart C, Le Guellec S, Vecellio L, Liistro G, et al. Effect of three-drug delivery modalities on olfactory function in chronic sinusitis. Laryngoscope 2015;125:549–55.
- Vecellio L, De Gersem R, Le Guellec S, Reychler G, Pitance L, Le Pennec D, et al. Deposition of aerosols delivered by nasal route with jet and mesh nebulizers. Int J Pharm 2011;407:87–94.
- Lam K, Tan BK, Lavin JM, Meen E, Conley DB. Comparison of nasal sprays and irrigations in the delivery of topical agents to the olfactory mucosa. Laryngoscope 2013;123:2950–7.